Palonosetron (PALO) is effective in preventing acute and delayed chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC). - Aapro,M.S.; Bertoli,L.; Lordick,F. (Support Care Cancer, 2003)